Fecal transplants can make immunotherapy-refractory melanomas sensitive to checkpoint blockade, a finding that highlights the potential of manipulating gut bacteria to boost response rates to anti–PD-1 agents. Yet, how best to modulate the microbiome remains a matter of active debate.

©2021 American Association for Cancer Research.
2021
American Association for Cancer Research.
You do not currently have access to this content.